AI Medical Diagnostics
AI systems now detect diseases from medical imaging with accuracy surpassing specialists. From radiology to pathology, machine learning is transforming how we diagnose conditions early and accurately.
Discover how AI is revolutionizing medical diagnostics, drug discovery, surgical robotics, legal research, judicial prediction, and compliance across healthcare and law.
AI vs Humans in Medicine & Law — who does it better? Test your knowledge!
In-depth coverage of artificial intelligence transforming healthcare and the legal profession.
AI systems now detect diseases from medical imaging with accuracy surpassing specialists. From radiology to pathology, machine learning is transforming how we diagnose conditions early and accurately.
AI accelerates drug discovery from years to months by predicting molecular interactions, identifying drug candidates, and optimizing clinical trial design with unprecedented precision.
Robotic surgery systems enhance precision while AI-powered telemedicine platforms extend specialist care to remote areas, democratizing access to quality healthcare worldwide.
AI tools review thousands of contracts and legal documents in minutes, finding relevant precedents and clauses with accuracy that rivals experienced attorneys.
Predictive analytics help forecast case outcomes, assess recidivism risk, and optimize litigation strategies, while raising critical questions about bias and fairness in justice.
AI-powered compliance tools help hospitals meet HIPAA regulations and law firms ensure adherence to evolving legal standards, reducing risk and administrative burden.
The FDA granted approval to Paige AI's autonomous screening tool for detecting early-stage colorectal cancer from routine blood tests, marking the first AI system authorized to operate without direct physician oversight in primary care settings.
The European Court of Justice ruled that physicians remain legally liable for diagnoses made with AI assistance, establishing that AI tools are aids rather than independent medical decision-makers under EU health law.
Google DeepMind announced AlphaFold 3 has identified twelve novel protein targets for developing antibiotics against drug-resistant superbugs, with three candidates entering Phase I clinical trials by Q4 2026.
The Supreme Court heard oral arguments in Davis v. State on whether AI-powered recidivism prediction tools violate the Equal Protection Clause, a case that could reshape how predictive algorithms are used throughout the American justice system.
The World Health Organization released comprehensive guidelines for deploying AI in medical imaging across 194 member states, covering validation requirements, bias testing protocols, and minimum accuracy thresholds for clinical deployment.
Luminance's AI platform completed due diligence review of 85,000 contracts in a $14 billion pharmaceutical merger in just 72 hours, a process that previously required teams of 50+ lawyers working for months.
Japan's Ministry of Health launched a nationwide screening program using AI analysis of CT scans to detect pancreatic cancer up to two years before clinical symptoms, initially targeting 10 million adults over age 50.
China's National People's Congress passed the Judicial AI Regulation Act, requiring transparency reports for all AI systems used in courts, mandatory bias audits, and establishing citizens' right to challenge AI-influenced judicial decisions.
Johns Hopkins researchers reported that the STAR robotic system successfully performed a fully autonomous laparoscopic intestinal anastomosis on live tissue, achieving precision metrics comparable to expert surgeons in a controlled clinical trial.
The IBA published binding ethical guidelines for AI use in legal practice across 190 jurisdictions, covering client data protection, disclosure obligations when AI generates legal documents, and standards for AI-assisted litigation strategy.